Regeneron Pharma (REGN) PT Lowered to $888 at Barclays
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $805.97 +1.00%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $888.00 (from $915.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Applied Aerospace & Defense (AADX) PT Lowered to $23 at BofA Securities
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,278 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
